Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.

Literature DB >> 2940969

Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare.

Abstract

The in vitro activity of ciprofloxacin, ofloxacin, amifloxacin, and norfloxacin against 22 clinical isolates of Mycobacterium tuberculosis was evaluated by agar dilution. The MICs for 90% of the isolates of ciprofloxacin and ofloxacin were 0.5 and 1 microgram/ml, respectively. Amifloxacin and norfloxacin were less active. The MICs for 90% of the isolates of ciprofloxacin and ofloxacin against 20 clinical isolates of Mycobacterium intracellulare were determined by agar dilution to be 2 and 8 micrograms/ml, respectively.

Entities: Chemical Species

Mesh：

Substances：

Year: 1986 PMID： 2940969 PMCID： PMC180399 DOI： 10.1128/AAC.29.3.386

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

16 in total

1. In vitro activity of ciprofloxacin against mycobacteria.

Authors: H Gaya; M V Chadwick
Journal: Eur J Clin Microbiol Date: 1985-06 Impact factor: 3.267

2. Pharmacokinetics of three oral formulations of ciprofloxacin.

Authors: R L Davis; J R Koup; J Williams-Warren; A Weber; A L Smith
Journal: Antimicrob Agents Chemother Date: 1985-07 Impact factor: 5.191

3. Pharmacokinetics and tissue penetration of ciprofloxacin.

Authors: B Crump; R Wise; J Dent
Journal: Antimicrob Agents Chemother Date: 1983-11 Impact factor: 5.191

4. Pharmacokinetics of intravenously administered ciprofloxacin.

Authors: R Wise; R M Lockley; M Webberly; J Dent
Journal: Antimicrob Agents Chemother Date: 1984-08 Impact factor: 5.191

5. In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.

Authors: M Tsukamura
Journal: Microbiol Immunol Date: 1983 Impact factor: 1.955

6. In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.

Authors: J D Gay; D R DeYoung; G D Roberts
Journal: Antimicrob Agents Chemother Date: 1984-07 Impact factor: 5.191

7. In vitro activity of amoxicillin in combination with clavulanic acid against Mycobacterium tuberculosis.

Authors: M H Cynamon; G S Palmer
Journal: Antimicrob Agents Chemother Date: 1983-09 Impact factor: 5.191

8. Norfloxacin disposition after sequentially increasing oral doses.

Authors: B N Swanson; V K Boppana; P H Vlasses; H H Rotmensch; R K Ferguson
Journal: Antimicrob Agents Chemother Date: 1983-02 Impact factor: 5.191

9. Multiple-dose pharmacokinetics and safety of ciprofloxacin in normal volunteers.

Authors: M A Gonzalez; F Uribe; S D Moisen; A P Fuster; A Selen; P G Welling; B Painter
Journal: Antimicrob Agents Chemother Date: 1984-11 Impact factor: 5.191

Review 10. Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature.

Authors: C R Horsburgh; U G Mason; D C Farhi; M D Iseman
Journal: Medicine (Baltimore) Date: 1985-01 Impact factor: 1.889

34 in total

1. Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.

Authors: G E Pfyffer; D A Bonato; A Ebrahimzadeh; W Gross; J Hotaling; J Kornblum; A Laszlo; G Roberts; M Salfinger; F Wittwer; S Siddiqi
Journal: J Clin Microbiol Date: 1999-10 Impact factor: 5.948

2. Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages.

Authors: S Majumdar; D Flasher; D S Friend; P Nassos; D Yajko; W K Hadley; N Düzgüneş
Journal: Antimicrob Agents Chemother Date: 1992-12 Impact factor: 5.191

Review 3. Susceptibility testing of Mycobacterium avium complex isolates.

Authors: L Heifets
Journal: Antimicrob Agents Chemother Date: 1996-08 Impact factor: 5.191

4. Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice.

Authors: J Conley; H Yang; T Wilson; K Blasetti; V Di Ninno; G Schnell; J P Wong
Journal: Antimicrob Agents Chemother Date: 1997-06 Impact factor: 5.191

Review 5. Mycobacteria and the new quinolones.

Authors: D C Leysen; A Haemers; S R Pattyn
Journal: Antimicrob Agents Chemother Date: 1989-01 Impact factor: 5.191

6. Rapid broth macrodilution method for determination of MICs for Mycobacterium avium isolates.

Authors: S H Siddiqi; L B Heifets; M H Cynamon; N M Hooper; A Laszlo; J P Libonati; P J Lindholm-Levy; N Pearson
Journal: J Clin Microbiol Date: 1993-09 Impact factor: 5.948

7. Efficacies of liposome-encapsulated clarithromycin and ofloxacin against Mycobacterium avium-M. intracellulare complex in human macrophages.

Authors: C O Onyeji; C H Nightingale; D P Nicolau; R Quintiliani
Journal: Antimicrob Agents Chemother Date: 1994-03 Impact factor: 5.191

8. Synthesis of some nucleosides derivatives from L- rhamnose with expected biological activity.

Authors: Amira Atef Ghoneim
Journal: Chem Cent J Date: 2011-02-11 Impact factor: 4.215

9. Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex.

Authors: V J LaBombardi; L Cataldo-Caputzal
Journal: Antimicrob Agents Chemother Date: 1993-07 Impact factor: 5.191

10. Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.

Authors: J L Whiting; N Cheng; A W Chow
Journal: Antimicrob Agents Chemother Date: 1987-09 Impact factor: 5.191